chr17-74748804-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_004252.5(NHERF1):c.-43C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0138 in 1,531,540 control chromosomes in the GnomAD database, including 190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0079 ( 10 hom., cov: 33)
Exomes 𝑓: 0.014 ( 180 hom. )
Consequence
NHERF1
NM_004252.5 5_prime_UTR
NM_004252.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.204
Genes affected
NHERF1 (HGNC:11075): (NHERF family PDZ scaffold protein 1) This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009]
SLC9A3R1-AS1 (HGNC:55322): (SLC9A3R1 antisense RNA 1)
MIR3615 (HGNC:38905): (microRNA 3615) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 17-74748804-C-A is Benign according to our data. Variant chr17-74748804-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 1316123.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00787 (1198/152272) while in subpopulation SAS AF = 0.0188 (91/4830). AF 95% confidence interval is 0.0157. There are 10 homozygotes in GnomAd4. There are 542 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1198 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHERF1 | NM_004252.5 | c.-43C>A | 5_prime_UTR_variant | Exon 1 of 6 | ENST00000262613.10 | NP_004243.1 | ||
SLC9A3R1-AS1 | NR_187307.1 | n.929G>T | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||
MIR3615 | NR_037409.1 | n.*105C>A | downstream_gene_variant | |||||
MIR3615 | unassigned_transcript_3091 | n.*121C>A | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHERF1 | ENST00000262613 | c.-43C>A | 5_prime_UTR_variant | Exon 1 of 6 | 1 | NM_004252.5 | ENSP00000262613.5 | |||
NHERF1 | ENST00000583369 | c.-43C>A | 5_prime_UTR_variant | Exon 1 of 3 | 3 | ENSP00000464321.1 | ||||
SLC9A3R1-AS1 | ENST00000585285.1 | n.109G>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 3 | |||||
MIR3615 | ENST00000581999.1 | n.*105C>A | downstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.00787 AC: 1197AN: 152154Hom.: 10 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1197
AN:
152154
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0104 AC: 1712AN: 164426 AF XY: 0.0115 show subpopulations
GnomAD2 exomes
AF:
AC:
1712
AN:
164426
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0144 AC: 19909AN: 1379268Hom.: 180 Cov.: 27 AF XY: 0.0147 AC XY: 10070AN XY: 684374 show subpopulations
GnomAD4 exome
AF:
AC:
19909
AN:
1379268
Hom.:
Cov.:
27
AF XY:
AC XY:
10070
AN XY:
684374
Gnomad4 AFR exome
AF:
AC:
72
AN:
32288
Gnomad4 AMR exome
AF:
AC:
227
AN:
38378
Gnomad4 ASJ exome
AF:
AC:
158
AN:
25108
Gnomad4 EAS exome
AF:
AC:
0
AN:
37956
Gnomad4 SAS exome
AF:
AC:
1618
AN:
81028
Gnomad4 FIN exome
AF:
AC:
108
AN:
35146
Gnomad4 NFE exome
AF:
AC:
17074
AN:
1066032
Gnomad4 Remaining exome
AF:
AC:
608
AN:
57710
Heterozygous variant carriers
0
999
1998
2998
3997
4996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00787 AC: 1198AN: 152272Hom.: 10 Cov.: 33 AF XY: 0.00728 AC XY: 542AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
1198
AN:
152272
Hom.:
Cov.:
33
AF XY:
AC XY:
542
AN XY:
74456
Gnomad4 AFR
AF:
AC:
0.00255004
AN:
0.00255004
Gnomad4 AMR
AF:
AC:
0.00483471
AN:
0.00483471
Gnomad4 ASJ
AF:
AC:
0.00518732
AN:
0.00518732
Gnomad4 EAS
AF:
AC:
0.000193798
AN:
0.000193798
Gnomad4 SAS
AF:
AC:
0.0188406
AN:
0.0188406
Gnomad4 FIN
AF:
AC:
0.00225946
AN:
0.00225946
Gnomad4 NFE
AF:
AC:
0.0128096
AN:
0.0128096
Gnomad4 OTH
AF:
AC:
0.00567108
AN:
0.00567108
Heterozygous variant carriers
0
62
123
185
246
308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 17, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=300/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at